Filing Details
- Accession Number:
- 0001415889-25-008972
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-25 19:37:03
- Reporting Period:
- 2025-03-24
- Filing Date:
- 2025-03-25
- Accepted Time:
- 2025-03-25 19:37:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1727196 | Scholar Rock Holding Corp | SRRK | Biological Products, (No Disgnostic Substances) (2836) | 823750435 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790859 | Erin Moore | 301 Binney Street Cambridge MA 02142 | Interim Pfo And Pao | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-24 | 5,000 | $23.86 | 87,609 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-03-24 | 8,564 | $13.52 | 96,173 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-24 | 13,564 | $33.12 | 82,609 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-03-24 | 5,000 | $0.00 | 5,000 | $23.86 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-03-24 | 8,564 | $0.00 | 8,564 | $13.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,764 | 2028-10-25 | No | 4 | M | Direct | |
| 40,724 | 2030-02-06 | No | 4 | M | Direct |
Footnotes
- These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024.
- Consists of 20,380 shares of common stock and 67,229 RSUs.
- Consists of 28,944 shares of common stock and 67,229 RSUs.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.00 to $33.55, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Consists of 15,380 shares of common stock and 67,229 RSUs.
- No shares remain unvested under this stock option.
Billionaire Hedge Funds
